Cargando…
Pathogenesis and progression of anosmia and dysgeusia during the COVID-19 pandemic
Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) is the causative agent of COVID-19 which was detected in late 2019 in Wuhan, China. As of September 2022, there have been over 612 million confirmed cases of COVID-19 with over 6.5 million associated deaths. In many cases, anosmia and...
Autores principales: | Krishnakumar, Hari N., Momtaz, David A., Sherwani, Anusha, Mhapankar, Aum, Gonuguntla, Rishi K., Maleki, Ariana, Abbas, Adam, Ghali, Abdullah N., Al Afif, Ayham |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548302/ https://www.ncbi.nlm.nih.gov/pubmed/36209486 http://dx.doi.org/10.1007/s00405-022-07689-w |
Ejemplares similares
-
Contribution of anosmia and dysgeusia for diagnostic of COVID-19 in outpatients
por: Zayet, Souheil, et al.
Publicado: (2020) -
Potential Mechanisms for COVID-19 Induced Anosmia and Dysgeusia
por: Eshraghi, Adrien A., et al.
Publicado: (2020) -
Anosmia and dysgeusia in COVID-19: A systematic review
por: Carrillo-Larco, Rodrigo M., et al.
Publicado: (2020) -
Can symptoms of anosmia and dysgeusia be diagnostic for COVID‐19?
por: Zahra, Syeda Anum, et al.
Publicado: (2020) -
Anosmia and dysgeusia as markers of severity and prognosis in COVID-19
por: Carpio-Orantes, Luis Del, et al.
Publicado: (2023)